After the CoAT boost, the induced T-cell response was relatively high in the LS-CoAT and LS-CoAT +αPD-1 groups, whereas the αPD-1 monotherapy group and untreated animals continued to have only low frequencies of tumor-specific CD8+ T cells in the peripheral blood (Fig. 4C). This evidence concerns the gene CD8A and neoplasm.